Nanoluciferase-based cell fusion assay for rapid and high-throughput assessment of SARS-CoV-2-neutralizing antibodies in patient samples

After more than two years, COVID-19 still represents a global health burden of unprecedented extent and assessing the degree of immunity of individuals against SARS-CoV-2 remains a challenge. Virus neutralization assays represent the gold standard for assessing antibody-mediated protection against S...

Descripción completa

Detalles Bibliográficos
Autores principales: Meyrath, Max, Szpakowska, Martyna, Plesseria, Jean-Marc, Domingues, Olivia, Langlet, Jérémie, Weber, Bernard, Krüger, Rejko, Ollert, Markus, Chevigné, Andy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9459433/
https://www.ncbi.nlm.nih.gov/pubmed/36220277
http://dx.doi.org/10.1016/bs.mie.2022.07.015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9459433/
https://www.ncbi.nlm.nih.gov/pubmed/36220277
http://dx.doi.org/10.1016/bs.mie.2022.07.015

Ejemplares similares